Company intelligence / Profile preview

RevoNA Bio

Portsmouth, Hampshire, UKrevona.bio ↗

Ownership: Private
Development stage: Other

Overview

RevoNA Bio is a pre-seed stage biotechnology startup developing a novel high-throughput platform for the rapid discovery of drugs targeting RNA. The company integrates advanced biological data generation with machine learning to accelerate and reduce the cost of identifying new therapeutics that act on RNA. No clinical results have been reported yet as the company is in early-stage development.

Therapeutic areas: Other
Modalities: RNA therapySmall molecule
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed, but open to collaborations and pilots

Beyond the preview

Go deeper on RevoNA Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RevoNA Bio.

Explore the full profile